Evaluation of serum midkine levels and metabolic parameters in patients with hidradenitis suppurativa

[1]  G. Wang,et al.  Midkine: a multifaceted driver of atherosclerosis. , 2021, Clinica chimica acta; international journal of clinical chemistry.

[2]  G. Jemec,et al.  Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  Tolga Düzenli,et al.  Midkine level may be used as a noninvasive biomarker in Crohn’s disease , 2020, Turkish journal of medical sciences.

[4]  G. Kokolakis,et al.  Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System , 2019, Dermatology.

[5]  T. Turhan,et al.  Serum Midkine Levels in Patients with Psoriasis , 2020 .

[6]  B. Strober,et al.  Part I. Hidradenitis Suppurativa: Epidemiology, clinical presentation, and pathogenesis. , 2019, Journal of the American Academy of Dermatology.

[7]  Xiaoping Zhou,et al.  Diagnostic accuracy of midkine for hepatocellular carcinoma: A meta‐analysis , 2019, Molecular genetics & genomic medicine.

[8]  A. Aynacioglu,et al.  Involvement of midkine in autoimmune and autoinflammatory diseases , 2018, Modern rheumatology.

[9]  M. Suárez-Fariñas,et al.  Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature , 2018, PloS one.

[10]  T. Ergun.  Hidradenitis suppurativa and the metabolic syndrome. , 2018, Clinics in dermatology.

[11]  A. Kimball,et al.  Comorbidities of hidradenitis suppurativa , 2017, Seminars in cutaneous medicine and surgery.

[12]  H. Naik,et al.  Complications of hidradenitis suppurativa , 2017, Seminars in cutaneous medicine and surgery.

[13]  H. Shimada,et al.  The growth factor midkine may play a pathophysiological role in rheumatoid arthritis , 2017, Modern rheumatology.

[14]  D. Ye,et al.  Elevated plasma midkine and pleiotrophin levels in patients with systemic lupus erythematosus , 2016, Oncotarget.

[15]  P. Mertens,et al.  Midkine, a heparin-binding growth factor, and its roles in atherogenesis and inflammatory kidney diseases. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  B. Walzog,et al.  PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS The cytokine midkine supports neutrophil traf fi cking during acute in fl ammation by promoting adhesion via b 2 integrins ( CD 11 / CD 18 ) , 2014 .

[17]  R. Liu,et al.  Midkine, a Potential Link between Obesity and Insulin Resistance , 2014, PloS one.

[18]  P. Ferdinandy,et al.  Therapeutic potential of midkine in cardiovascular disease , 2014, British journal of pharmacology.

[19]  Tamio Suzuki,et al.  Expression of midkine in normal human skin, dermatitis and neoplasms: Association with differentiation of keratinocytes , 2013, The Journal of dermatology.